
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 7.470 | 7.470 | 0.000 |
Shares | 93.450 | 93.450 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.478 | 19.008 |
Price to Book | 3.493 | 2.547 |
Price to Sales | 3.558 | 2.004 |
Price to Cash Flow | 14.515 | 12.000 |
Dividend Yield | 2.051 | 2.319 |
5 Years Earnings Growth | 9.209 | 13.122 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 89.680 | 8.215 |
Industrials | 5.440 | 22.847 |
Consumer Defensive | 4.880 | 9.153 |
Number of long holdings: 25
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Zhejiang Jolly Pharma | CNE100001096 | 7.93 | 18.90 | -1.20% | |
Hunan Fangsheng Pharm | CNE100001VG6 | 7.83 | 10.85 | -1.63% | |
Mabwell Shanghai Bioscience | CNE100005RD2 | 6.98 | 34.87 | -3.51% | |
Ningbo Sanxing Medical Electric | CNE100001567 | 5.08 | 22.80 | +0.04% | |
Xiamen Amoytop Biotech Co | CNE100003RT3 | 4.78 | 85.74 | -1.15% | |
Beijing New Oriental Star Petro Eng | CNE100001X92 | 4.65 | 26.73 | -5.04% | |
InventisBio | CNE100005Q22 | 4.60 | 42.28 | -2.13% | |
Humanwell Healthcare | CNE000000QW6 | 4.57 | 21.72 | -0.64% | |
Runben Biotechnology | CNE100006DK5 | 4.56 | 32.09 | -0.96% | |
Shanghai Allist Pharmaceuticals Co | CNE100005XJ7 | 4.50 | 95.74 | -3.69% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Lord Value Advantage Stock Fund | 1.83B | 3.57 | -13.79 | 5.84 | ||
LACAM China Cyclical Strategy Equit | 606.05M | 1.56 | -13.06 | 6.51 | ||
Lord Growth Advantage Stock Fund | 125.96M | 1.33 | -9.33 | 3.62 | ||
Lord Theme Dynamic Asset Allocation | 9.72M | 1.82 | -9.78 | 0.97 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review